Richard F. Olsson

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Development and performance of a next generation sequencing (NGS) assay for monitoring of dd-cfDNA post solid organ transplantation.

Development and performance of a next generation sequencing (NGS) assay for monitoring of dd-cfDNA post solid organ transplantation.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: October 24, 2023

Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.

Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.

Journal: Bone marrow transplantation

Published: March 17, 2022

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Journal: Haematologica

Published: August 01, 2021

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.

Journal: Leukemia

Published: June 06, 2021

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Journal: Bone marrow transplantation

Published: May 21, 2021

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.

Journal: Transplantation and cellular therapy

Published: May 17, 2021

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.

Journal: Bone marrow transplantation

Published: May 13, 2021

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.

Journal: Transplantation and cellular therapy

Published: May 05, 2021

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.

Journal: Blood advances

Published: April 06, 2021

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.

Journal: Blood advances

Published: March 31, 2021

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.

Journal: Leukemia

Published: March 30, 2021

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Journal: Current oncology (Toronto, Ont.)

Published: December 31, 2020

Showing 1-12 of 112

Last Updated: 09/26/2026